There are 2846 resources available
Next generation synthetic lethal target discovery using high-throughput CRISPR technology
Presenter: Matthew Garnett
Session: Exploiting synthetic lethality: The next generation
Resources:
Slides
Webcast
Organ-specific tumour microenvironment
Presenter: Adil Daud
Session: How the tumour microenvironment affects outcome and therapy response?
Resources:
Slides
Webcast
Mucosal melanoma
Presenter: Jessica Hassel
Session: Advances in non-cutaneous melanoma
Resources:
Slides
Webcast
Targeting the uncommon molecular alterations
Presenter: Andrea Sartore Bianchi
Session: Are novel immunotherapeutics and targeted treatments going to transform the management of CRC?
Resources:
Slides
Webcast
HER2+ advanced breast cancer
Presenter: Shanu Modi
Session: Updates in the standard of care of metastatic breast cancer
Resources:
Slides
Webcast
New drugs for ultrarare sarcoma
Presenter: Silvia Stacchiotti
Session: Ultra-rare sarcoma: Navigating an endless sea
Resources:
Slides
Webcast
518O - Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mutation
Presenter: Amit Oza
Session: Proffered Paper session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Long term follow-up on single arm registration studies: what have we learned?
Presenter: Bishal Gyawali
Session: 5-year impact of new registered indications on the ESMO-MCBS
Resources:
Slides
Webcast
The impact of COVID-19 on surgery
Presenter: Francoise Rimareix
Session: The impact of COVID-19 on patients with cancer: Lessons learnt and pathway for the future
Resources:
Slides
Webcast
Is germline testing needed and does it impact treatment decisions?
Presenter: Elena Castro Marcos
Session: Using molecular data that impacts clinical practice
Resources:
Slides
Webcast